A polygenic risk score (PRS) for ANA+ and for SLE was constructed and compared in patients with SLE, ANA+ and ANA negative (ANA−) individuals without autoimmune disease and general controls who never had ANA testing performed. This evidence concerns the gene BTG3 and systemic lupus erythematosus.